These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15934910)

  • 21. Cancer angiogenesis: targeting the heel of Achilles.
    Dass CR; Choong PF
    J Drug Target; 2008 Jul; 16(6):449-54. PubMed ID: 18604657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic inhibition of angiogenesis.
    Zhang HT; Bicknell R
    Mol Biotechnol; 2003 Oct; 25(2):185-200. PubMed ID: 14526126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Metronomic chemotherapy in 2011: update and perspectives].
    Benbrahim Z; Massard C; El Mesbahi O
    Bull Cancer; 2011 Dec; 98(12):1447-54. PubMed ID: 22146261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent developments in tumor angiogenesis.
    Kilarski WW; Bikfalvi A
    Curr Pharm Biotechnol; 2007 Feb; 8(1):3-9. PubMed ID: 17311548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Robustness of optimal controls for a class of mathematical models for tumor anti-angiogenesis.
    Schättler H; Ledzewicz U; Cardwell B
    Math Biosci Eng; 2011 Apr; 8(2):355-69. PubMed ID: 21631134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel angiogenesis inhibitors: addressing the issue of redundancy in the angiogenic signaling pathway.
    Ribatti D
    Cancer Treat Rev; 2011 Aug; 37(5):344-52. PubMed ID: 21435792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective induction of tumor ischemia: development of vascular targeting agents for cancer therapy.
    Chaplin DJ; Hill SA
    Curr Opin Investig Drugs; 2002 Sep; 3(9):1381-4. PubMed ID: 12498016
    [No Abstract]   [Full Text] [Related]  

  • 28. Design and development of polymer conjugates as anti-angiogenic agents.
    Segal E; Satchi-Fainaro R
    Adv Drug Deliv Rev; 2009 Nov; 61(13):1159-76. PubMed ID: 19699248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiangiogenic strategies and agents in clinical trials.
    Rosen L
    Oncologist; 2000; 5 Suppl 1():20-7. PubMed ID: 10804087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumour and dendrimers: a review on drug delivery aspects.
    Agarwal A; Asthana A; Gupta U; Jain NK
    J Pharm Pharmacol; 2008 Jun; 60(6):671-88. PubMed ID: 18498702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrin-Targeted Peptide- and Peptidomimetic-Drug Conjugates for the Treatment of Tumors.
    Arosio D; Manzoni L; Corno C; Perego P
    Recent Pat Anticancer Drug Discov; 2017; 12(2):148-168. PubMed ID: 28164756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiogenesis inhibitors in early development for gastric cancer.
    Pinto MP; Owen GI; Retamal I; Garrido M
    Expert Opin Investig Drugs; 2017 Sep; 26(9):1007-1017. PubMed ID: 28770623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ErbB targeted drugs and angiogenesis.
    Iivanainen E; Elenius K
    Curr Vasc Pharmacol; 2010 May; 8(3):421-31. PubMed ID: 19485914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimizing the delivery of cancer drugs that block angiogenesis.
    Cao Y; Langer R
    Sci Transl Med; 2010 Jan; 2(15):15ps3. PubMed ID: 20371469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liposomes targeting tumour stromal cells.
    Kuijpers SA; Coimbra MJ; Storm G; Schiffelers RM
    Mol Membr Biol; 2010 Oct; 27(7):328-40. PubMed ID: 20939769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-angiogenesis in neuroblastoma.
    Ribatti D
    Crit Rev Oncol Hematol; 2013 Jun; 86(3):212-21. PubMed ID: 23273512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiogenesis research: guidelines for translation to clinical application.
    Folkman J; Browder T; Palmblad J
    Thromb Haemost; 2001 Jul; 86(1):23-33. PubMed ID: 11487011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The preclinical evaluation of angiogenesis inhibitors.
    O'Reilly MS
    Invest New Drugs; 1997; 15(1):5-13. PubMed ID: 9195285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases.
    Fallah A; Sadeghinia A; Kahroba H; Samadi A; Heidari HR; Bradaran B; Zeinali S; Molavi O
    Biomed Pharmacother; 2019 Feb; 110():775-785. PubMed ID: 30554116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metronomic chemotherapy: Back to the future!
    André N; Padovani L; Verschuur A
    Drug News Perspect; 2010 Mar; 23(2):143-51. PubMed ID: 20369080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.